Medicine & Life Sciences
Neoplasms
100%
Neoplasm Metastasis
72%
Survival
69%
Hepatocellular Carcinoma
69%
Liver
65%
Pancreatic Neoplasms
58%
Adenocarcinoma
56%
Breast Neoplasms
47%
Vascular Endothelial Growth Factor A
36%
Therapeutics
34%
Pancreaticoduodenectomy
30%
Surgeons
29%
Drug Therapy
26%
Recurrence
24%
Breast
23%
Adrenocortical Carcinoma
21%
Peritoneal Neoplasms
20%
Stomach Neoplasms
19%
Fibrosis
18%
Liver Neoplasms
18%
Colorectal Neoplasms
18%
Neuroendocrine Tumors
18%
Growth
17%
Lymph Nodes
17%
Guidelines
17%
Lymph Node Excision
16%
Sentinel Lymph Node
16%
Oncologists
15%
Blood Vessels
15%
Cholangiocarcinoma
15%
Mortality
14%
Phosphatidylserines
13%
Vascular Endothelial Growth Factor Receptor-2
13%
Hepatectomy
13%
Carcinoma
13%
Proteins
12%
Robotics
12%
Pancreatectomy
12%
Heterografts
12%
Cysteine
12%
Radiofrequency Ablation
12%
Confidence Intervals
12%
Sarcoma
12%
Colonic Neoplasms
12%
Odds Ratio
12%
Neoadjuvant Therapy
11%
Discoidin Domain Receptor 1
11%
T-Lymphocytes
11%
Pancreas
11%
Stomach
10%
Wounds and Injuries
10%
Palliative Care
10%
Tumor Microenvironment
10%
Melanoma
9%
Peptoids
9%
Radiotherapy
9%
Mutation
9%
Segmental Mastectomy
9%
Peritoneal Diseases
9%
Databases
9%
Safety-net Providers
9%
Antibodies
9%
Radiologists
9%
Vascular Endothelial Growth Factor Receptor
9%
Non-Small Cell Lung Carcinoma
9%
Margins of Excision
8%
Rectal Neoplasms
8%
Clinical Trials
8%
Adjuvant Chemotherapy
8%
Lung
8%
Population
8%
Liver Diseases
8%
Incidence
8%
Safety
8%
Operating Rooms
8%
Cytoreduction Surgical Procedures
7%
Morbidity
7%
Physicians
7%
Practice Guidelines
7%
Dissection
7%
Cancer-Associated Fibroblasts
7%
Extracellular Matrix
7%
Pathologists
7%
Macrophages
7%
Lung Neoplasms
7%
Meta-Analysis
7%
Liver Transplantation
7%
Genes
7%
Collagen
7%
Lymphangiogenesis
7%
Randomized Controlled Trials
7%
Endothelial Cells
6%
Hispanic Americans
6%
Ultrasonography
6%
Length of Stay
6%
Spiral Computed Tomography
6%
Propensity Score
6%
Sentinel Lymph Node Biopsy
6%
Antigens
6%
Interleukin-10
6%